Cerity Partners’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
Other funds holding LUNG
SCM
ECM
AC
SCM
B
Cerity Partners's LUNG Position: Q2 2026 in Review
Cerity Partners increased its Pulmonx (LUNG) stake by 32% in Q2 2026, buying an estimated $12.8K and bringing the position to 38,143 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3301.
Cerity Partners first reported a position in LUNG in Q4 2025 and has held it in 3 quarters since. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.
- Cerity Partners held 38,143 shares of Pulmonx worth $49.6K as of Q2 2026.
- Cerity Partners bought 9,307 Pulmonx shares in Q2 2026, an estimated $12.8K.
- Pulmonx made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3301 holding.
- Cerity Partners first reported a position in Pulmonx in Q4 2025 and has held it in 3 quarters since.
- 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.